Accreditation
Provider Statement
Provided by HMP Education, an HMP Global Company.
Intended Learners
This educational activity is designed for interventional radiologists, vascular surgeons, interventional cardiologists, cardiothoracic surgeons, clinical cardiologists, clinical radiologists, neurologists, physician assistants, nurse practitioners and vascular ultrasound technologists.
Learning Objectives
After completing this activity, participants should be able to:
- Understand current trends in noninvasive diagnostic testing techniques to diagnose, plan treatment for, and follow cardiovascular disease
- Analyze recommendations for IAC stenosis velocity criteria
- Evaluate patients for failing or poorly maturing dialysis access and review sonographic criteria for percutaneous arteriovenous fistula creation
- Assess findings from venous duplex testing in patients with deep venous reflux, chronic pelvic pain disorders, COVID, and after venous stenting to improve patient outcomes
- Analyze renal and mesenteric arterial studies and understand fibromuscular dysplasia (FMD) and vasculitis
- Compare and contrast techniques of Doppler imaging
Activity Overview
To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who complete the evaluation online within 1 year of the training will receive immediate documentation of credit. For questions regarding this educational activity, please email accreditation@hmpglobal.com.
Release Date:December 8, 2023
Expiration Date: December 8, 2024
Estimated Time to Complete: 18.75 hours. See individual courses for credit amounts.
Hardware/Software Requirements
The activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications.
Continuing Education
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Physicians
HMP Education designates this enduring activity for 18.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ARDMS Acceptance
American Medical Association (AMA) Physicians Recognition Award, Category 1 CME meets the requirements of the ARDMS Accepted Continuing Education Evaluation Model System (AACEEMS). You may submit your CME credits to ARDMS.
ARDMS Credentials:
- RDMS® Registered Diagnostic Medical Sonographer®
- RDCS® Registered Diagnostic Cardiac Sonographer®
- RVT® Registered Vascular Technologist®
- RPVI® Registered Physicians Vascular Interpretation®
CCI Acceptance
This ACCME accredited CEU opportunity meets the Category 1 requirements of the Cardiovascular Credentialing International (CCI) credential maintenance acceptance policy. You may submit your CME credits to CCI.
CCI Credentials:
- Advanced Cardiac Sonographer (ACS)
- RCS: Registered Cardiac Sonographer
- RVS: Registered Vascular Specialist
- CCT: Certified Cardiographic Technician
Nurses
This continuing nursing education enduring activity awards 18.75 contact hours.
Provider approved by the California Board of Registered Nursing. Provider
Nurse Practitioners
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Physician Assistants
HMP Education has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 18.75 AAPA Category 1 credits. Approval valid until December 8, 2024. PAs should claim only credit commensurate with the extent of their participation
Use of Proprietary Names
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
Unapproved and/or Investigational Uses of Drugs and Devices
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters, or moderators and do not necessarily reflect the opinions of HMP Education.
Disclaimers
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own health care provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Disclosure of Relevant Financial Relationships
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
All relevant financial relationships have been mitigated.
Faculty
The faculty has reported the following:
John Angle: Consultant–Endoron; Grant/Research Support–Siemens Medical
Bulent Arslan: Advisory Board–AngioDynamics; Consultant–AngioDynamics, Medtronic; Speakers Bureau–Bard, Cook Medical, Medtronic, Penumbra
Joshua Beckman: Consultant–Amgen, JanOne, Janssen, Novartis
James Benenati: Penumbra–Other Financial or Material Support, Chief Medical Officer
Yolanda Bryce: Consultant–Hologic; Grant/Research Support–Bristol Myers Squibb Foundation, Society to Improve Medical Diagnosis
Anthony Comerota: Consultant–Co-PI for Zilver Vena Venous Stent Trial
Mary Costantino: Consultant–Siemens Medical; Other Financial or Material Support, small amount of stock–Medtronic, Merit Medical
Michael Jaff: Consultant–Gilde Healthcare, McKinsey, Nectero, Vactronix, Venarum Major Stockholder–Healthcare Insights, Primacea, R3 Vascular Other Financial or Material Support, Part-time employee–Boston Scientific Corporation; Other Financial or Material Support, Investor–Efemoral, Embolitech, Janacare, Nectero, R3 Vascular, Sano V, Vascular Therapies
Raghu Kolluri: Advisory Board–Penumbra, Philips; Consultant–Abbott Vascular, Boston Scientific, Inari, Medtronic, Philips, Surmodics, Vesper a Philips Company; Other Financial or Material Support–Mercador, Syntropic CoreLab, Thrombolex, Vesper a Philips Company, VIVA Physicians Inc
Nicos Labropoulos: Consultant–Philips; Speakers Bureau–BD Bard, Boston Scientific, Medtronic
Joseph Lombardi: Consultant–Cook Medical; Investigator–Cook Medical
Derek Mittleider: Advisory Board–Boston Scientific Corporation; Consultant–Boston Scientific Corporation, Inari Medica; Speakers Bureau–Boston Scientific Corporation, Inari Medica
Patrick Muck: Advisory Board–Boston Scientific; Consultant–Penumbra; Speakers Bureau–Abbott Vascular, Cook Medical, Penumbra, Shockwave Medical, Terumo Aortic, W. L. Gore; Major Stockholder–Penumbra
Alex Powell: Consultant–Penumbra; Speakers Bureau–Penumbra
John Rundback: Advisory Board–Abbott, AngioDynamics, Avail, Boston Scientific, Cardiovascular Systems, Medtronic, Philips; Consultant–AngioDynamics, Cardiovascular Systems, Vesper; Grant/Research Support–Abbott, Boston Scientific, Cardiovascular Systems, Medtronic, Micro Medical Solutions; Speakers Bureau–Abbott, AngioDynamics, Avail, Boston Scientific, Cardiovascular Systems, Medtronic, Philips, Vesper; Other Financial or Material Support–Abbott, Cardiovascular Systems, Micro Medical Solutions, Vesper; Research Institutional Support–AngioDynamics, Avail, Boston Scientific; Stockholder/Ownership Interest–AVAIL
Fadi Saab: Consultant–Bectin Dickinson, Boston Scientific, Cardiovascular Systems Inc., Medtronic; Grant/Research Support—Boston Scientific, CardioFlow, Endologix (PQ Bypass); Major Stockholder—CardioFlow
Gloria Salazar: Advisory Board–Avail Med Systems, Medtronic; Consultant–Avail Med Systems, Medtronic; Speaker's Bureau–Medtronic
Brian Schiro: Consultant–Philips; Speakers Bureau–Medtronic, Penumbra, Philips, Sirtex
Libby Watch: Consultant–Silk Road
PLANNING COMMITTEE
James Benenati, MD, FSIR
Dr. James F. Benenati, MD, FSIR
Miami Cardiac & Vascular Institute, Miami, FL
Ian Del Conde, MD
Director of Vascular Medicine
Miami Cardiac and Vascular Institute
Rich Neville, MD
Chairman, Department of Surgery, Associate Director of Inova Heart and Vascular Institute Inova
Brian Schiro, MD
Interventional Radiologist
Miami Cardiac & Vascular Institute
Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California
Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).
HMP Education planners and staff include Kristin Ciszeski; Krystal Scharon; Samantha Joy; Randy Robbin; and Andrea Zimmerman, EdD.
No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
ADA Statement
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodations, please call 609.371.1137.
Privacy Policy
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2024 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Grievance Policy
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609.371.1137, by email at sjoy@hmpglobal.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Joy will review the grievance and respond within 30 days of receiving the complaint.
Commercial Support
No commercial interest provided financial support for this continuing education activity.
Contact Information
For questions regarding this educational activity, please call 609.371.1137 or email accreditation@hmpglobal.com.
Copyright © 2023 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Provider Statement
Provided by HMP Education, an HMP Global Company.
Intended Learners
This educational activity is designed for interventional radiologists, vascular surgeons, interventional cardiologists, cardiothoracic surgeons, clinical cardiologists, clinical radiologists, neurologists, physician assistants, nurse practitioners and vascular ultrasound technologists.
Learning Objectives
After completing this activity, participants should be able to:
- Understand current trends in noninvasive diagnostic testing techniques to diagnose, plan treatment for, and follow cardiovascular disease
- Analyze recommendations for IAC stenosis velocity criteria
- Evaluate patients for failing or poorly maturing dialysis access and review sonographic criteria for percutaneous arteriovenous fistula creation
- Assess findings from venous duplex testing in patients with deep venous reflux, chronic pelvic pain disorders, COVID, and after venous stenting to improve patient outcomes
- Analyze renal and mesenteric arterial studies and understand fibromuscular dysplasia (FMD) and vasculitis
- Compare and contrast techniques of Doppler imaging
Activity Overview
To be eligible for documentation of credit, participants must attend the full activity and submit a completed evaluation form. Participants who complete the evaluation online within 1 year of the training will receive immediate documentation of credit. For questions regarding this educational activity, please email accreditation@hmpglobal.com.
Release Date:December 8, 2023
Expiration Date: December 8, 2024
Estimated Time to Complete: 18.75 hours. See individual courses for credit amounts.
Hardware/Software Requirements
The activity is best supported via a computer or device with current versions of the following browsers: Mozilla Firefox, Google Chrome, or Safari. A PDF reader is required for print publications.
Continuing Education
In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Note: This statement is not an indication of approved credits. Please see below for full accreditation details, including credit types and totals, for this activity.
Physicians
HMP Education designates this enduring activity for 18.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ARDMS Acceptance
American Medical Association (AMA) Physicians Recognition Award, Category 1 CME meets the requirements of the ARDMS Accepted Continuing Education Evaluation Model System (AACEEMS). You may submit your CME credits to ARDMS.
ARDMS Credentials:
- RDMS® Registered Diagnostic Medical Sonographer®
- RDCS® Registered Diagnostic Cardiac Sonographer®
- RVT® Registered Vascular Technologist®
- RPVI® Registered Physicians Vascular Interpretation®
CCI Acceptance
This ACCME accredited CEU opportunity meets the Category 1 requirements of the Cardiovascular Credentialing International (CCI) credential maintenance acceptance policy. You may submit your CME credits to CCI.
CCI Credentials:
- Advanced Cardiac Sonographer (ACS)
- RCS: Registered Cardiac Sonographer
- RVS: Registered Vascular Specialist
- CCT: Certified Cardiographic Technician
Nurses
This continuing nursing education enduring activity awards 18.75 contact hours.
Provider approved by the California Board of Registered Nursing. Provider
Nurse Practitioners
American Academy of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.
Physician Assistants
HMP Education has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with the AAPA CME Criteria. This enduring activity is designated for 18.75 AAPA Category 1 credits. Approval valid until December 8, 2024. PAs should claim only credit commensurate with the extent of their participation
Use of Proprietary Names
This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.
Unapproved and/or Investigational Uses of Drugs and Devices
This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters, or moderators and do not necessarily reflect the opinions of HMP Education.
Disclaimers
The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a provider-patient relationship. Medical advice of any nature should be sought from an individual’s own health care provider.
The opinions expressed in this educational activity are those of the faculty and are not attributable to HMP Global or any of its subsidiaries or affiliates. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Disclosure of Relevant Financial Relationships
HMP Education is an independent provider of continuing medical education. HMP Education has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.
In accordance with our disclosure policies, HMP Education is committed to ensuring balance, independence, objectivity, and scientific rigor for all accredited continuing education. These policies include assigning relevance to, and mitigating, all perceived or real relevant financial relationship (conflicts of interest) between any individual with control over the content and any ineligible company (commercial interest) as defined by the ACCME and CPME.
Any individual with control over accredited content, including planner, faculty, and reviewer, is required to globally disclose:
- Individual relationship(s) or lack thereof, and its nature, with any/all ineligible company, and;
- Any investigational, off-label, or non-FDA approved content or discussion
HMP Education has reviewed these disclosures, assigned relevance based on the relationship and scope of content, and identified those with the potential to compromise the goals and educational integrity of the education. Relevant relationships, or lack thereof, are shared with the learner.
Education has been independently peer-reviewed to validate content, mitigate identified financial relationships (conflicts of interest), and ensure:
- All recommendations involving clinical medicine is based on evidence that is accepted within the medical profession as adequate justification for their indications and contraindications in the care of patients.
- All scientific research referred to, reported, or used in accredited continuing education in support or justification of a patient care recommendation conforms to the generally accepted standards of experimental design, data collection, and analysis.
- Content is appropriate, fair and balanced, unbiased, referenced, and non-promotional.
All relevant financial relationships have been mitigated.
Faculty
The faculty has reported the following:
John Angle: Consultant–Endoron; Grant/Research Support–Siemens Medical
Bulent Arslan: Advisory Board–AngioDynamics; Consultant–AngioDynamics, Medtronic; Speakers Bureau–Bard, Cook Medical, Medtronic, Penumbra
Joshua Beckman: Consultant–Amgen, JanOne, Janssen, Novartis
James Benenati: Penumbra–Other Financial or Material Support, Chief Medical Officer
Yolanda Bryce: Consultant–Hologic; Grant/Research Support–Bristol Myers Squibb Foundation, Society to Improve Medical Diagnosis
Anthony Comerota: Consultant–Co-PI for Zilver Vena Venous Stent Trial
Mary Costantino: Consultant–Siemens Medical; Other Financial or Material Support, small amount of stock–Medtronic, Merit Medical
Michael Jaff: Consultant–Gilde Healthcare, McKinsey, Nectero, Vactronix, Venarum Major Stockholder–Healthcare Insights, Primacea, R3 Vascular Other Financial or Material Support, Part-time employee–Boston Scientific Corporation; Other Financial or Material Support, Investor–Efemoral, Embolitech, Janacare, Nectero, R3 Vascular, Sano V, Vascular Therapies
Raghu Kolluri: Advisory Board–Penumbra, Philips; Consultant–Abbott Vascular, Boston Scientific, Inari, Medtronic, Philips, Surmodics, Vesper a Philips Company; Other Financial or Material Support–Mercador, Syntropic CoreLab, Thrombolex, Vesper a Philips Company, VIVA Physicians Inc
Nicos Labropoulos: Consultant–Philips; Speakers Bureau–BD Bard, Boston Scientific, Medtronic
Joseph Lombardi: Consultant–Cook Medical; Investigator–Cook Medical
Derek Mittleider: Advisory Board–Boston Scientific Corporation; Consultant–Boston Scientific Corporation, Inari Medica; Speakers Bureau–Boston Scientific Corporation, Inari Medica
Patrick Muck: Advisory Board–Boston Scientific; Consultant–Penumbra; Speakers Bureau–Abbott Vascular, Cook Medical, Penumbra, Shockwave Medical, Terumo Aortic, W. L. Gore; Major Stockholder–Penumbra
Alex Powell: Consultant–Penumbra; Speakers Bureau–Penumbra
John Rundback: Advisory Board–Abbott, AngioDynamics, Avail, Boston Scientific, Cardiovascular Systems, Medtronic, Philips; Consultant–AngioDynamics, Cardiovascular Systems, Vesper; Grant/Research Support–Abbott, Boston Scientific, Cardiovascular Systems, Medtronic, Micro Medical Solutions; Speakers Bureau–Abbott, AngioDynamics, Avail, Boston Scientific, Cardiovascular Systems, Medtronic, Philips, Vesper; Other Financial or Material Support–Abbott, Cardiovascular Systems, Micro Medical Solutions, Vesper; Research Institutional Support–AngioDynamics, Avail, Boston Scientific; Stockholder/Ownership Interest–AVAIL
Fadi Saab: Consultant–Bectin Dickinson, Boston Scientific, Cardiovascular Systems Inc., Medtronic; Grant/Research Support—Boston Scientific, CardioFlow, Endologix (PQ Bypass); Major Stockholder—CardioFlow
Gloria Salazar: Advisory Board–Avail Med Systems, Medtronic; Consultant–Avail Med Systems, Medtronic; Speaker's Bureau–Medtronic
Brian Schiro: Consultant–Philips; Speakers Bureau–Medtronic, Penumbra, Philips, Sirtex
Libby Watch: Consultant–Silk Road
PLANNING COMMITTEE
James Benenati, MD, FSIR
Dr. James F. Benenati, MD, FSIR
Miami Cardiac & Vascular Institute, Miami, FL
Ian Del Conde, MD
Director of Vascular Medicine
Miami Cardiac and Vascular Institute
Rich Neville, MD
Chairman, Department of Surgery, Associate Director of Inova Heart and Vascular Institute Inova
Brian Schiro, MD
Interventional Radiologist
Miami Cardiac & Vascular Institute
Susie Seaman, NP, MSN, CWCN, CWS (nurse planner)
Wound Clinic, Family Health Centers of San Diego
San Diego, California
Ms. Seaman has disclosed no relevant financial relationship with any ineligible company (commercial interest).
HMP Education planners and staff include Kristin Ciszeski; Krystal Scharon; Samantha Joy; Randy Robbin; and Andrea Zimmerman, EdD.
No HMP Education planner or staff has disclosed a relevant financial relationship with any ineligible company (commercial interest).
ADA Statement
HMP Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity needs accommodations, please call 609.371.1137.
Privacy Policy
HMP Education protects the privacy of personal and other information regarding participants, educational partners, and joint providers. HMP Education and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. HMP Education maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2024 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.
Grievance Policy
Any participant wanting to file a grievance with respect to any aspect of a continuing education activity accredited by HMP Education may contact Samantha Joy, Senior Manager, Accreditation and Compliance, by phone at 609.371.1137, by email at sjoy@hmpglobal.com, or in writing at 104 Windsor Center Drive, East Windsor, NJ 08520. Ms. Joy will review the grievance and respond within 30 days of receiving the complaint.
Commercial Support
No commercial interest provided financial support for this continuing education activity.
Contact Information
For questions regarding this educational activity, please call 609.371.1137 or email accreditation@hmpglobal.com.
Copyright © 2023 by HMP Education. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from HMP Education.